Thank you to the IMCAS Organizers for the opportunity to participate as Speaker and Faculty Member and present WINDOME BANKING PARTNERS’s perspectives on the Aesthetics market overview: present and future in the context of this hallmark 25th Edition of the IMCAS Conference which broke all records with 18,500 attendees and demonstrated once more its unstoppable…
Thank you to the IMCAS Organizers for the opportunity to participate as Speaker and Faculty Member and present WINDOME BANKING PARTNERS’s perspectives on the Aesthetics market overview: present and future in the context of this hallmark 25th Edition of the IMCAS Conference which broke all records with 18,500 attendees and demonstrated once more its unstoppable resilience and recession-proof character.
2023 was a challenging year due to the macroeconomic backdrop and the erosion of Personal Disposable Incomes for such discretionary spendings, caused by inflation and the drastic rise in interest rates freezing EBD CAPEX-Plans. However, we could witness a turnaround and resurgence driven by sustainable and global irreversible megatrends which continue to amplify regardless of external market conditions and an ever-complexifying regulatory environment such as the quest for leapfrogging game-changers, personalization of protocols, prejuvenation and the empowerment of patients fueled by social networks, as well as construction of powerhouse aesthetics ecosystems engaging into immersive experiential journeys and daily skincare rituals, matching an holistic approach of anti-ageing and wellbeing. The proliferation of the GLP-1 analogues treatments for obesity could also develop a transformative impact on fillers usage, as patients need to revolumize, retighten and refirm their facial, neck and décolleté to mitigate the skin laxity effects of such treatment. In any case, there is a perceptible sense of recovery with numerous M&A transactions announced as of the beginning of 2024, both in the Medical Aesthetics (Lutronic/Cynosure), as well as in the Dermocosmetics spaces (Bridgepoint/ROC Skincare, Compass Diversified/The Honey Pot, L’Occitane/Dr. Vranjes Firenze)
AI empowers the man-machine relationship, where virtual environments gain intelligence to become more interactive and drives a formidable productivity boom, while AI-augmented Previsualization and simulation techniques facilitate the conversion from considerers to patients and accelerate the learning curve
The New Year has already hit on all cylinders with a number of medium-sized and large cross-border and national M&A transactions in the EBD segment as well as in dermocosmetics, bringing to fruition a number of the 2023 most advanced pipeline projects, hybrid forms of partnership transactions have multiplied reflecting the convergence towards an ever more integrated ecosystem and one-stop-shop of medical aesthetics and dermocosmetics as well as nutraceuticals “combined solutions” in a personalized approach to the patients.
We look forward to a reacceleration of the growth curve propelled by the exponential proliferation of genAI, web 3 and the virtualization of aesthetics, paving the way for a new era in this industry.
#IMCAS #Aesthetics #cosmeceuticals #aestheticinjectables #skincare #markettrends #aestheticsurgery #noninvasivetreatment #paris IMCAS # IMCASACADEMY, #médecineesthétique #bienêtre #medicalaesthetic #wellness #médecine #thinktank #thinktankesthetiquemédicale #chirurgieesthetique #medecineantiage #dermatologieesthetique #esthetiquemedicale #journéescientifique #excellenceesthetiquemedicalefrançaise #paris #france
